Deborah Fuller's lab has worked nonstop for months to test vaccine platforms against SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Several new findings on how the virus’ cell entry tools operate could expedite the design of vaccines, antibodies, antivirals and other therapeutics.
